{"symbol": "THTX", "name": "Theratechnologies", "next_earnings_utc": 1594726200, "next_earnings_period_start_date_utc": 1582934400, "next_earnings_period_end_date_utc": 1590883200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q2", "next_earnings_year": 2020, "next_earnings_quarter": 2, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": 16956040.76310344, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": -0.04996173143974827, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 3, "total_analysts": 5, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 2, "analysts_underperform": 0, "webpage": "theratech.com", "year_founded": 1993, "street_address": "2015 Peel Street", "city": "Montreal", "state": "QC", "zipcode": "H3A 1T8", "country": "Canada", "phone_number": "514 336 7800", "short_description": "Theratechnologies Inc., a biopharmaceutical company, markets prescription products in the United States, Europe, and Canada.", "long_description": "Theratechnologies Inc., a biopharmaceutical company, markets prescription products in the United States, Europe, and Canada. It offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. The company's pipeline products include F8 Formulation that could be used for the treatment of HIV-associated lipodystrophy; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was founded in 1993 and is headquartered in Montreal, Canada.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 154926177, "total_enterprise": 174066531, "number_of_employees": 42, "outstanding_shares": 77013411, "eps": -0.205492, "diluted_eps": -0.205492, "earnings_from_cont_operations": -15812000, "gross_profit": 30218000, "cash": 34579000, "total_debt": 54225000, "total_revenue": 63839000, "cash_from_operations": -11949000, "net_income": -15812000, "ebitda": -3743000, "year_low_stock_price": 1.79, "year_high_stock_price": 2.63, "seekingalpha_follower_count": 1338, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/THTX.png"}